Article Details

DESTINY-Gastric05 Phase 3 Trial of ENHERTU® Initiated in Patients with Previously ...

Retrieved on: 2025-03-31 16:27:08

Tags for this article:

Click the tags to see associated articles and topics

DESTINY-Gastric05 Phase 3 Trial of ENHERTU® Initiated in Patients with Previously .... View article details on hiswai:

Excerpt

ENHERTU consists of a HER2 monoclonal antibody attached to a number of topoisomerase I inhibitor payloads (an exatecan derivative, DXd) via ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo